Evidence and policy making. The introduction of MMR vaccine in the Netherlands

S. Blume, J. Tump

Research output: Contribution to JournalArticleAcademicpeer-review


Based on a case-study of the introduction of measles-mumps-rubella (MMR) vaccine in the Netherlands two decades ago, using documentary and archival sources, this paper examines the way evidence is used in policymaking. Starting from the question of 'what counts as evidence', two central claims are developed. First, the decision to introduce MMR was not one but a series of decisions going back at least seven years, over the course of which the significance attached to various forms of evidence changed. Second, results of international studies were coming gradually to be of greater significance than evidence gathered from within the Netherlands itself. These developments had, and continue to have, major consequences for national scientific competences. © 2010 Elsevier Ltd.
Original languageEnglish
Pages (from-to)1049-1055
Number of pages7
JournalSocial Science and Medicine
Issue number6
Publication statusPublished - 2010


Dive into the research topics of 'Evidence and policy making. The introduction of MMR vaccine in the Netherlands'. Together they form a unique fingerprint.

Cite this